Non Hodgkin Lymphoma Clinical Trial

Proton Therapy for Hodgkin Lymphoma

Summary

The purpose of this study is to reduce the risk of radiation related side effects and complications by treating with radiation (protons or photons) that exposes less of normal organs to low dose radiation.

View Full Description

Full Description

3 treatment plans will be created to deliver between a total of 21-39.6 Gray (Gy)/Centigray Equivalents (CGE) to the planning target volume (PTV).

Proton Plan
Conventional Plan
Intensity Modulated Radiotherapy (IMRT) Plan

The patient will then receive the radiation modality with the lowest percentage of the body receiving 4 Gy (V4Gy/CGE)

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Confirmed "classic" Hodgkin lymphoma.
Completed chemotherapy.

Exclusion Criteria:

Prior radiotherapy.
Prior or concurrent cancer other than non-melanomatous skin cancer.

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

20

Study ID:

NCT00850200

Recruitment Status:

Completed

Sponsor:

University of Florida

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Florida Proton Therapy Institute
Jacksonville Florida, 32206, United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

20

Study ID:

NCT00850200

Recruitment Status:

Completed

Sponsor:


University of Florida

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider